​
​

SIGA (SIGA) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChartTranscripts

SIGA Revenue Highlights

Latest Revenue (Y)

$139.92M

Latest Revenue (Q)

$10.01M

Main Segment (Y)

Research and Development

Main Geography (Y)

Research and Development

SIGA Revenue by Period

SIGA Revenue by Year

DateRevenueChange
2023-12-31-26.31%
2022-12-31--17.13%
2021-12-31-6.97%
2020-12-31-367.28%
2019-12-31--94.39%
2018-12-31-3788.30%
2017-12-31--18.14%
2016-12-31-83.32%
2015-12-31-160.39%
2014-12-31--43.11%
2013-12-31--38.48%
2012-12-31--29.51%
2011-12-31--33.77%
2010-12-31-39.13%
2009-12-31-71.24%
2008-12-31-20.41%
2007-12-31--7.70%
2006-12-31--14.38%
2005-12-31-360.90%
2004-12-31-151.34%
2003-12-31-112.44%
2002-12-31--70.29%
2001-12-31-140.00%
2000-12-31--3.38%
1999-12-31--
1998-12-31--28.57%
1997-12-31-600.00%
1996-12-31--

SIGA generated $139.92M in revenue during NA 2023, up 26.31% compared to the previous quarter, and up 29.33% compared to the same period a year ago.

SIGA Revenue by Quarter

DateRevenueChange
2024-09-30--54.11%
2024-06-30--14.23%
2024-03-31--78.17%
2023-12-31-1161.27%
2023-09-30-57.11%
2023-06-30--29.37%
2023-03-31--26.72%
2022-12-31--84.27%
2022-09-30-333.26%
2022-06-30-58.14%
2022-03-31--90.86%
2021-12-31-2280.38%
2021-09-30--44.00%
2021-06-30-79.76%
2021-03-31--87.24%
2020-12-31--14.76%
2020-09-30-9.70%
2020-06-30-1440.17%
2020-03-31--38.56%
2019-12-31--47.43%
2019-09-30-107.58%
2019-06-30--62.64%
2019-03-31-566.48%
2018-12-31--99.67%
2018-09-30-17601.51%
2018-06-30-52.25%
2018-03-31-23.76%
2017-12-31-1.59%
2017-09-30--67.40%
2017-06-30--18.02%
2017-03-31--27.33%
2016-12-31-53.66%
2016-09-30-145.01%
2016-06-30-49.74%
2016-03-31--69.69%
2015-12-31-215.57%
2015-09-30--9.54%
2015-06-30-23.10%
2015-03-31-41.85%
2014-12-31--23.56%
2014-09-30-68.98%
2014-06-30-18.42%
2014-03-31--41.18%
2013-12-31--59.25%
2013-09-30-137.61%
2013-06-30--27.38%
2013-03-31--47.16%
2012-12-31-9.79%
2012-09-30--15.23%
2012-06-30-84.29%
2012-03-31--70.45%
2011-12-31-38.63%
2011-09-30-43.63%
2011-06-30-46.82%
2011-03-31--44.59%
2010-12-31--53.83%
2010-09-30-49.14%
2010-06-30--12.38%
2010-03-31-28.32%
2009-12-31-0.85%
2009-09-30--2.17%
2009-06-30-108.17%
2009-03-31--22.61%
2008-12-31-33.61%
2008-09-30-7.54%
2008-06-30--12.64%
2008-03-31-12.49%
2007-12-31--

SIGA generated $10.01M in revenue during Q3 2024, up -54.11% compared to the previous quarter, and up 170.29% compared to the same period a year ago.

SIGA Revenue Breakdown

SIGA Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 19Dec 18
Research and Development--
Product Sales and Supportive Services--

SIGA's latest annual revenue breakdown by segment (product or service), as of Dec 19: Research and Development (58.16%), and Product Sales and Supportive Services (41.84%).

Quarterly Revenue by Product

Product/ServiceSep 24Jun 24Mar 24Dec 19Sep 19Jun 19Mar 19Dec 18Sep 18
Product Sales and Supportive Services---------
Research and Development---------

SIGA's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Product Sales and Supportive Services (89.34%), and Research and Development (10.66%).

SIGA Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 19Dec 18
Product Sales and Supportive Services--
Research and Development--

SIGA's latest annual revenue breakdown by geography, as of Dec 19: Research and Development (58.16%), and Product Sales and Supportive Services (41.84%).

Quarterly Revenue by Country

CountrySep 24Jun 24Mar 24Dec 19Sep 19Jun 19Mar 19Dec 18Sep 18
Non-US---------
UNITED STATES---------
EMEA---------
Asia Pacific---------
CANADA---------
Product Sales and Supportive Services---------
Research and Development---------

SIGA's latest quarterly revenue breakdown by geography, as of Sep 24: UNITED STATES (84.57%), Non-US (7.72%), and EMEA (7.72%).

SIGA Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
RDYDr. Reddy's Laboratories--
PTPIPetros Pharmaceuticals--
ELANElanco Animal Health--
CTLTCatalent--
NBIXNeurocrine Biosciences--
ALKSAlkermes--
PAHCPhibro Animal Health--
PCRXPacira BioSciences--
COLLCollegium Pharmaceutical--
IRWDIronwood Pharmaceuticals--
ORGOOrganogenesis--
DCPHDeciphera Pharmaceuticals--
SIGASIGA--
ESPREsperion Therapeutics--
ALIMAlimera Sciences--
AVDLAvadel Pharmaceuticals--
SSICSilver Spike Investment--
SXTCChina SXT Pharmaceuticals--
LSDILucy Scientific Discovery--
SHPHShuttle Pharmaceuticals--

SIGA Revenue FAQ

What is SIGA’s yearly revenue?

SIGA's yearly revenue for 2023 was $139.92M, representing an increase of 26.31% compared to 2022. The company's yearly revenue for 2022 was $110.78M, representing a decrease of -17.13% compared to 2021. SIGA's yearly revenue for 2021 was $133.67M, representing an increase of 6.97% compared to 2020.

What is SIGA’s quarterly revenue?

SIGA's quarterly revenue for Q3 2024 was $10.01M, a -54.11% decrease from the previous quarter (Q2 2024), and a 8.39% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $21.81M, a -14.23% decrease from the previous quarter (Q1 2024), and a 271.05% increase year-over-year (Q2 2023). SIGA's quarterly revenue for Q1 2024 was $25.43M, a -78.17% decrease from the previous quarter (Q4 2023), and a 205.54% increase year-over-year (Q1 2023).

What is SIGA’s revenue growth rate?

SIGA's revenue growth rate for the last 3 years (2021-2023) was 4.67%, and for the last 5 years (2019-2023) was 423.21%.

What are SIGA’s revenue streams?

SIGA's revenue streams in c 19 are Research and Development, and Product Sales and Supportive Services. Research and Development generated $15.55M in revenue, accounting 58.16% of the company's total revenue, up 91.17% year-over-year. Product Sales and Supportive Services generated $11.19M in revenue, accounting 41.84% of the company's total revenue, down -97.61% year-over-year.

What is SIGA’s main source of revenue?

For the fiscal year ending Dec 19, the largest source of revenue of SIGA was Research and Development. This segment made a revenue of $15.55M, representing 58.16% of the company's total revenue.